Description
ABBOTT ALINITY M REAGENTS AND CONSUMABLES OY2
Base award description: ABBOTT ALINITY M REAGENTS AND CONSUMABLES
Modification chain · 7 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2024-03-27+$612,771= $612,771
- Mod P000022024-05-08+$0= $612,771
- Mod P000032024-10-01+$1,826,981= $2,439,752
- Mod P000042025-01-31-$155,882= $2,283,870
- Mod P000052025-10-01+$1,826,981= $4,110,851
- Mod P000062026-01-26-$379,455= $3,731,396
- Mod P000072026-01-28-$44,371= $3,687,026
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2024-03-27 | +$612,771 | $612,771 | ABBOTT ALINITY M REAGENTS AND CONSUMABLES |
| Mod P00002· OTHER ADMINISTRATIVE ACTION | 2024-05-08 | +$0 | $612,771 | CHANGE LOA |
| Mod P00003· EXERCISE AN OPTION | 2024-10-01 | +$1,826,981 | $2,439,752 | ABBOTT ALINITY M REAGENTS AND CONSUMABLES |
| Mod P00004· FUNDING ONLY ACTION | 2025-01-31 | −$155,882 | $2,283,870 | ABBOTT ALINITY M REAGENTS AND CONSUMABLES |
| Mod P00005· EXERCISE AN OPTION | 2025-10-01 | +$1,826,981 | $4,110,851 | ABBOTT ALINITY M REAGENTS AND CONSUMABLES OY2 |
| Mod P00006· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2026-01-26 | −$379,455 | $3,731,396 | ABBOTT ALINITY M REAGENTS AND CONSUMABLES OY2 |
| Mod P00007· OTHER ADMINISTRATIVE ACTION | 2026-01-28 | −$44,371 | $3,687,026 | ABBOTT ALINITY M REAGENTS AND CONSUMABLES OY2 |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI NK5QDVJBHMN7)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24126N0799 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $658,750 | FY2026 |
| 36C26326P0588 | NETWORK CONTRACT OFFICE 23 (36C263) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $308,299 | FY2026 |
| 36C24126A0041 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $0 | FY2026 |
| 36C24226N0439 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $1,481,077 | FY2026 |
| 36C24926N0423 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $471,122 | FY2026 |
| 36C24626N0476 | 246-NETWORK CONTRACTING OFFICE 6 (36C246) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $421,178 | FY2026 |
Other recipients under 6550 from 261-NETWORK CONTRACT OFFICE 21 (36C261) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C26126N0364 | BIOMERIEUX INC | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $112,848 | FY2026 |
| 36C26126N0371 | RLS (USA) INC. | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $250,075 | FY2026 |
| 36C26126P0448 | ROCHE DIAGNOSTICS CORPORATION | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $120,976 | FY2026 |
| 36C26126F0102 | WERFEN USA LLC | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $79,671 | FY2026 |
| 36C26126P0353 | HEMOSONICS, LLC | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $82,300 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26124F0252_3600_V797P7323A_3600 · retrieved 2026-09-26.